APA (7th ed.) Citation

Kimura, Y., Aiba, S., Ashikaga, T., Ohishi, T., & Kushima, K. (2023). Adverse Outcome Pathway on impaired interleukin-1 receptor type I (IL-1R1) signaling leading to impaired T-cell dependent antibody response. OECD Publishing.

Chicago Style (17th ed.) Citation

Kimura, Yutaka, Setsuya Aiba, Takao Ashikaga, Takumi Ohishi, and Kiyoshi Kushima. Adverse Outcome Pathway on Impaired Interleukin-1 Receptor Type I (IL-1R1) Signaling Leading to Impaired T-cell Dependent Antibody Response. Paris: OECD Publishing, 2023.

MLA (9th ed.) Citation

Kimura, Yutaka, et al. Adverse Outcome Pathway on Impaired Interleukin-1 Receptor Type I (IL-1R1) Signaling Leading to Impaired T-cell Dependent Antibody Response. OECD Publishing, 2023.